Management strategies for SSRI induced sexual dysfunction

Journal of Psychiatry and Neuroscience

Volumn 38, Issue 5, 2013, Pages

  Rizvi, Sakina J ^a,b   Kennedy, Sidney H ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGOMELATINE; AMFEBUTAMONE; BUSPIRONE; CITALOPRAM; DEXAMPHETAMINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; METHYLPHENIDATE; MILNACIPRAN; MIRTAZAPINE; MOCLOBEMIDE; PAROXETINE; PLACEBO; PRAMIPEXOLE; REBOXETINE; ROPINIROLE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; TADALAFIL; VENLAFAXINE; VILAZODONE;

ADULT; ANORGASMIA; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR DEPRESSION; SEXUAL AROUSAL; SEXUAL DYSFUNCTION; VAGINAL LUBRICATION;

FEMALE; HUMANS; MIDDLE AGED; PSYCHOTROPIC DRUGS; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 84884991416     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.130076     Document Type: Article

References (35)

1. Keltner NL, McAfee KM, Taylor CL. Mechanisms and treatments of SSRIinduced sexual dysfunction. Perspect Psychiatr Care 2002;38:111-6.
2. Montejo AL, Llorca G, Izquierdo J, et al. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. J Clin Psychiatry 2001;62:10-21.
3. Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psycho -pharmacol 2009;29:259-66.
4. Kennedy SH, Rizvi S. Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol 2009; 29:157-64.
5. Bull SA, Hunkeler EM, Lee JY. Discontinuing or switching serotonin reuptake inhibitors. Ann Pharmacother 2002;36:578-84.
6. Hu XH, Bull SA, Hunkeler EM. Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. J Clin Psychiatry 2004; 65:959-65.
7. McGahuey CA, Gelenberg AJ, Laukes CA, et al. The Arizona Sexual Experience Scale: reliability and validity. J Sex Marital Ther 2000;26:25-40.
8. Clayton AH, McGarvey EL, Clavet GJ. The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity. Psychopharmacol Bull 1997;33:731-45.
9. Kennedy SH, Rizvi SJ, Fulton K. The sex effects scale: pilot validation in a healthy population. Psychopharmacol Bull 2010;43: 15-25.
10. Kennedy SH, Lam RW, Nutt DJ, et al. Treating depression effectively. Valley Stream, NY: Martin Dunitz; 2007.
11. Atmaca M, Korkmaz S, Topuz M, et al. Mirtazapine augmentation for selective serotonin reuptake inhibitor-induced sexual dysfunction: a retropective investigation. Psychiatry Investig 2011;8:55-7.
12. Ravindran LN, Eisfeld BS, Kennedy SH. Combining mirtazapine and duloxetine in treatment-resistant depression improves outcomes and sexual function. J Clin Psychopharmacol 2008b;28:107-8.
13. Aizenberg D, Zemishlany Z, Weizman A. Cyproheptadine treatment of sexual dysfunction induced serotonin reuptake inhibitors. Clin Neuropharmacol 1995;4: 320-4.
14. Lauerma H. Successful treatment of citalo pram-induced anorgasmia by cyproheptadine. Acta Psychiatr Scand 1996; 93:69-70.
15. Landén M, Eriksson E, Agren H, et al. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1999;19:268-71.
16. Fava M, Nurnberg HG, Seidman SN, et al. Efficacy and safety of sildenafil in men with serotonergic antidepressantassociated erectile dysfunction: results from a randomized, double-blind, placebocontrolled trial. J Clin Psychiatry 2006; 67:240-6.
17. Nurnberg HG, Hensley PL. Sildenafil citrate for the management of antidepressantassociated erectile dysfunction. J Clin Psychiatry 2003;64(Suppl 10):20-5.
18. Evliyaoglu Y, Yelsel K, Kobaner M, et al. Efficacy and tolerability of tadalafil for treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Urology 2011;77:1137-41.
19. Segraves RT, Lee J, Stevenson R, et al. Tadalafil for treatment of erectile dysfunction in men on antidepressants. J Clin Psychopharmacol 2007;27:62-6.
20. Nurnberg HG, Hensley PL, Heiman JR, et al. Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial. JAMA 2008;300:395-404.
21. Ashton AK, Weinstein W. Tadalafil reversal of sexual dysfunction caused by serotonin enhancing medications in women. J Sex Marital Ther 2006;32:1-3.
22. Zisook S, Rush AJ, Haight BR, et al. Use of bupropion in combination with serotonin reuptake inhibitors. Biol Psychiatry 2006; 59:203-10.
23. Clayton AH, Warnock JK, Kornstein SG, et al. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 2004;65:62-7.
24. Safarinejad MR. The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized study. BJU Int 2010;106:840-7.
25. Ravindran AV, Kennedy SH, O'Donovan MC, et al. Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a doubleblind, randomized, placebo-controlled trial. J Clin Psychiatry 2008a;69:87-94.
26. Balon R, Segraves RT. Survey of treatment practices for sexual dysfunction(s) associated with anti-depressants. J Sex Marital Ther 2008;34:353-65.
27. Worthington JJ III, Simon NM, Korbly NB, et al.; Anxiety Disorders Research Program. Ropinirole for antidepressantinduced sexual dysfunction. Int Clin Psychopharmacol 2002;17:307-10.
28. Aiken CB. Pramipexole in psychiatry: a systematic review of the literature. J Clin Psychiatry 2007;68:1230-6.
29. Reinhold JA, Mandos LA, Lohoff FW, et al. Evidence for the use of vilazodone in the treatment of major depressive disorder. Expert Opin Pharmacother 2012;13: 2215-24.
30. Lorenz TA, Meston CM. Acute exercise improves physical sexual arousal in women taking antidepressants. Ann Behav Med 2012;43:352-61.
31. Dhikav V, Karmarkar G, Gupta R, et al. Yoga in female sexual functions. J Sex Med 2010a;7:964-70.
32. Dhikav V, Karmarkar G, Verma M, et al. Yoga in male sexual functioning: a noncompararive pilot study. J Sex Med 2010b; 7:3460-6.
33. Jacobsen FM. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry 1992;53:119-22.
34. Michelson D, Kociban K, Tamura R, et al. Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial. J Psychiatr Res 2002;36:147-52.
35. Dording CM, Fisher L, Papakostas G, et al. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRIinduced sexual dysfunction. CNS Neurosci Ther 2008;14:182-91.